Details
Stereochemistry | ACHIRAL |
Molecular Formula | C34H41N7O5 |
Molecular Weight | 627.7332 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=NC=CC=C4)N2C)C=C1
InChI
InChIKey=KSGXQBZTULBEEQ-UHFFFAOYSA-N
InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)
Molecular Formula | C34H41N7O5 |
Molecular Weight | 627.7332 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:30:14 UTC 2023
by
admin
on
Fri Dec 15 16:30:14 UTC 2023
|
Record UNII |
2E18WX195X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C263
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
||
|
WHO-VATC |
QB01AE07
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
||
|
WHO-ATC |
B01AE07
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
70743
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
2E18WX195X
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
DB06695
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
213023
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
SUB20521
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
211915-06-9
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
m4064
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000089553
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
1037042
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | RxNorm | ||
|
776
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
CHEMBL539697
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
UU-126
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
DTXSID4057681
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
8028
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
C87480
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
70746
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
6379
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY | |||
|
2E18WX195X
Created by
admin on Fri Dec 15 16:30:15 UTC 2023 , Edited by admin on Fri Dec 15 16:30:15 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
FECAL
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
FECAL
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
FECAL
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
URINE
|
||
|
METABOLITE -> PARENT |
after p.o. administration of 200 mg of 14C dabigatran etexilate in healthy volunteers
TRACE AMOUNT
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|